Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
GCT02
i
Other names:
GCT02
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Myrio Therap
Drug class:
EGFRvIII-targeted CAR-T immunotherapy
Related drugs:
‹
CARv3-TEAM-E T cells (0)
DCTY0801 (0)
LXF821 (0)
SNC109 (0)
multi-target gene-modified CAR-T/TCR-T cell immunotherapy (0)
CARv3-TEAM-E T cells (0)
DCTY0801 (0)
LXF821 (0)
SNC109 (0)
multi-target gene-modified CAR-T/TCR-T cell immunotherapy (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login